Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek J Lomas

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
BMJ Open|October 1, 2021
ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRITeresa Marsden, Derek J Lomas, Neil McCartan, et al.
European Radiology|June 6, 2024
Natural language processing pipeline to extract prostate cancer-related information from clinical notesHirotsugu Nakai, Garima Suman, Daniel A Adamo, et al.
Cancers|June 27, 2024
A Description and Safety Overview of Irreversible Electroporation for Prostate Tissue Ablation in Intermediate-Risk Prostate Cancer Patients: Preliminary Results from the PRESERVE TrialArvin K George, Ranko Miocinovic, Amit R Patel, et al.
European Urology|July 20, 2025
Irreversible Electroporation for Prostate Tissue Ablation in Patients with Intermediate-risk Prostate Cancer: Results from the PRESERVE TrialArvin K George, Ranko Miocinovic, Amit R Patel, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
BMJ Open|October 1, 2021
ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRITeresa Marsden, Derek J Lomas, Neil McCartan, et al.
European Radiology|June 6, 2024
Natural language processing pipeline to extract prostate cancer-related information from clinical notesHirotsugu Nakai, Garima Suman, Daniel A Adamo, et al.
Cancers|June 27, 2024
A Description and Safety Overview of Irreversible Electroporation for Prostate Tissue Ablation in Intermediate-Risk Prostate Cancer Patients: Preliminary Results from the PRESERVE TrialArvin K George, Ranko Miocinovic, Amit R Patel, et al.
European Urology|July 20, 2025
Irreversible Electroporation for Prostate Tissue Ablation in Patients with Intermediate-risk Prostate Cancer: Results from the PRESERVE TrialArvin K George, Ranko Miocinovic, Amit R Patel, et al.
Pageof 3